AKT1 and myotonic dystrophy type 2: A 2017 study, which analyzed skeletal muscle biopsies and myotube cultures from DM1 and DM2 patients, found alterations in the basal phosphorylation levels of key signaling molecules, including Akt/PKB, p70S6K, GSK3β, and ERK1/2.